Dr. Armstrong Discusses Findings of ARCHES Trial in Prostate Cancer OncLive 1:38 5 years ago 198 Далее Скачать
Andrew Armstrong, MD, presents an overview of the ARCHES trial in mHSPC OBRoncology 2:07 5 years ago 66 Далее Скачать
ARCHES trial: androgen deprivation therapy with enzalutamide or placebo in mHSPC ecancer 3:43 5 years ago 310 Далее Скачать
Update on ARCHES trial: implications for prostate cancer treatment VJOncology 3:57 5 years ago 369 Далее Скачать
Dr. Armstrong on the Utility of Pamiparib and Other PARP Inhibitors in Prostate Cancer OncLive 1:00 4 years ago 195 Далее Скачать
Andrew Armstrong, MD, on determining treatment of prostate cancer with DNA repair markers OBRoncology 2:09 4 years ago 117 Далее Скачать
ENZAMET & ARCHES Trials Provides Evidence of Enzalutamide as Life Prolonging Therapy in mHSPC Grand Rounds in Urology 6:26 4 years ago 1 115 Далее Скачать
Dr. Andrew Armstrong on Precision Medicine Approaches in Advanced Prostate Cancer DocWire 9:53 2 years ago 100 Далее Скачать
Andrew Armstrong, MD, explains whether ARV-7 is predictive of response to taxanes in mPC patients OBRoncology 1:05 4 years ago 40 Далее Скачать
Dr. Armstrong on Precision Medicine for Metastatic Prostate Cancer OncLive 1:14 7 years ago 195 Далее Скачать
Andrew Armstrong, MD, discusses the Phase 2 STREAM study in pre-metastatic prostate cancer OBRoncology 1:18 5 years ago 22 Далее Скачать
New Approaches to Metastatic Hormone Sensitive Prostate Cancer Grand Rounds in Urology 17:44 4 years ago 8 198 Далее Скачать
Update on the ARCHES Trial: New Indication for Enzalutamide in mHSPC Grand Rounds in Urology 6:02 4 years ago 277 Далее Скачать
Dr. Armstrong on the utility of PARP Inhibitors in Mutated Prostate Cancer OncLive 0:57 4 years ago 112 Далее Скачать